ABBV vs. MU: AbbVie vs. Micron Stock Comparison

November 11, 2026

How do AbbVie (ABBV) and Micron (MU) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Micron (MU) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Micron (MU)
Profile Item	ABBV	MU
Name	AbbVie Inc.	Micron Technology Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Information Technology
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Semiconductors & Semiconductor Equipment
GICS Industry	Biotechnology	Semiconductors & Semiconductor Equipment
GICS Sub-Industry	Biotechnology	Semiconductors
Market Capitalization	514.92 billion USD	780.68 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	January 2, 2013	June 1, 1984
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABBV

GSPC

AbbVie (ABBV) vs. Micron (MU), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and Micron (MU). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for AbbVie (ABBV) and Micron (MU). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Total Return (1Y)	37.33%	208.53%
Total Return (3Y, Annualized)	32.74%	115.89%
Total Return (5Y, Annualized)	24.73%	58.28%

Risk Profile

Drawdown History

ABBV

GSPC

AbbVie (ABBV) vs. Micron (MU), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for AbbVie (ABBV) and Micron (MU). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Micron (MU) has a highly aggressive beta of 2.44, indicating much higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk profile metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Volatility (1Y, Annualized)	25.65%	83.85%
Beta (5Y)	0.21	2.44
Max Drawdown (5Y)	-21.92%	-57.63%
Avg. Volume (3M)	4.76M	27.63M

Risk-Adjusted Performance

Risk-Return Positioning

ABBV and MU are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Sharpe Ratio (1Y)	1.29	2.44
Sortino Ratio (1Y)	2.02	3.87

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Micron (MU) earns 88.26% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
ABBV: --

MU

Semiconductors & Semiconductor Equipment industry group

88.26%

MU: 88.26%
Max: 52.82%
Q3: 22.26%
Median: 10.58%
Q1: 1.29%
Min: -16.89%

AbbVie (ABBV) vs. Micron (MU): ABBV does not report ROE, so it has no value marker; MU is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and Micron (MU) at 63.80% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max: 18.05%
ABBV: 15.67%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

MU

Semiconductors & Semiconductor Equipment industry group

63.80%

MU: 63.80%
Max: 63.80%
Q3: 28.36%
Median: 11.44%
Q1: 0.90%
Min: -37.77%

AbbVie (ABBV) vs. Micron (MU): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Operating Margin (TTM)

Micron (MU) at 80.68% shows unusually strong operating efficiency — above its industry’s operating margin range — and AbbVie (ABBV) at 39.59% also operates in the top quartile.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max: 83.12%
ABBV: 39.59%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

MU

Semiconductors & Semiconductor Equipment industry group

80.68%

MU: 80.68%
Max: 58.66%
Q3: 30.23%
Median: 15.91%
Q1: 7.54%
Min: -25.74%

AbbVie (ABBV) vs. Micron (MU): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
ROE (TTM)	--	88.26%
ROA (TTM)	10.74%	44.56%
Net Margin (TTM)	15.67%	63.80%
Operating Margin (TTM)	39.59%	80.68%
Gross Margin (TTM)	73.72%	80.72%

Growth

Revenue Growth

Micron (MU) at 256.33% clears its industry range for revenue growth, far stronger top-line momentum than AbbVie (ABBV) at 8.57%, which is closer to a typical peer reading.

AbbVie (ABBV) vs. Micron (MU): A comparison of their Revenue Growth across different time periods.

EPS Growth

Micron (MU) at 879.31% clears its industry range for EPS growth, a much stronger earnings trajectory than AbbVie (ABBV) at -0.84%, which is closer to a typical peer reading.

AbbVie (ABBV) vs. Micron (MU): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Revenue Growth (YoY)	8.57%	256.33%
Revenue Growth (3Y CAGR)	1.75%	104.65%
EPS Growth (YoY)	-0.84%	879.31%
EPS Growth (3Y CAGR)	-29.03%	--

Financial Strength

Current Ratio (MRQ)

Micron (MU) at 3.31 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
ABBV: 0.87
Min: 0.10

MU

Semiconductors & Semiconductor Equipment industry group

3.31

Max: 10.33
Q3: 5.62
Median: 3.33
MU: 3.31
Q1: 2.35
Min: 1.03

AbbVie (ABBV) vs. Micron (MU): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Micron (MU) carries debt-to-equity ratio of 0.04 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 1.42
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

MU

Semiconductors & Semiconductor Equipment industry group

0.04

Max: 1.46
Q3: 0.65
Median: 0.27
Q1: 0.04
MU: 0.04
Min: 0.00

AbbVie (ABBV) vs. Micron (MU): ABBV does not report debt-to-equity ratio, so it has no value marker; MU is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Current Ratio (MRQ)	0.87	3.31
Debt / Equity (MRQ)	--	0.04
Net Debt / EBITDA	2.21	-0.35

Dividends

Dividend Yield (TTM)

Micron (MU) at 0.09% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV: 2.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

MU

Semiconductors & Semiconductor Equipment industry group

0.09%

Max: 1.37%
Q3: 0.65%
MU: 0.09%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Micron (MU): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Micron (MU) reports 0.71%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV: 117.35%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

MU

Semiconductors & Semiconductor Equipment industry group

0.71%

Max: 49.64%
Q3: 21.71%
MU: 0.71%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Micron (MU): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
Dividend Yield (TTM)	2.40%	0.09%
Dividend Payout Ratio (TTM)	117.35%	0.71%

Valuation

P/E Ratio (TTM)

Micron (MU) at 9.28 sits in the cheaper P/E ratio quartile, while AbbVie (ABBV) at 50.05 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max: 85.34
ABBV: 50.05
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

MU

Semiconductors & Semiconductor Equipment industry group

9.28

Max: 110.34
Q3: 66.81
Median: 37.02
Q1: 23.96
MU: 9.28
Min: 8.12

AbbVie (ABBV) vs. Micron (MU): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/S Ratio (TTM)

On P/S ratio, both AbbVie (ABBV) at 7.80 and Micron (MU) at 5.86 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max: 58.18
Q3: 25.77
ABBV: 7.80
Median: 7.30
Q1: 3.01
Min: 0.01

MU

Semiconductors & Semiconductor Equipment industry group

5.86

Max: 21.42
Q3: 12.27
MU: 5.86
Median: 5.76
Q1: 2.73
Min: 0.00

AbbVie (ABBV) vs. Micron (MU): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Micron (MU) reports 5.64, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59
ABBV: -112.34

MU

Semiconductors & Semiconductor Equipment industry group

5.64

Max: 14.06
Q3: 7.44
MU: 5.64
Median: 4.29
Q1: 2.30
Min: 0.20

AbbVie (ABBV) vs. Micron (MU): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Micron (MU)
Metric	ABBV	MU
P/E Ratio (TTM)	50.05	9.28
P/S Ratio (TTM)	7.80	5.86
P/B Ratio (MRQ)	-112.34	5.64
Free Cash Flow Yield (TTM)	3.44%	3.73%